Mayo Clinic Partners with Sana Biotech: A Potential One-Shot Treatment for Type 1 Diabetes
Sana + Mayo Clinic are testing SC451, a cell therapy that may treat type 1 diabetes without daily insulin shots or immune drugs.
/ 1 item
#SANA↓